PMC:7696151 / 24629-24811 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"705","span":{"begin":55,"end":62},"obj":"Species"},{"id":"730","span":{"begin":68,"end":110},"obj":"Disease"},{"id":"731","span":{"begin":127,"end":142},"obj":"Disease"}],"attributes":[{"id":"A705","pred":"tao:has_database_id","subj":"705","obj":"Tax:9606"},{"id":"A730","pred":"tao:has_database_id","subj":"730","obj":"MESH:D001172"},{"id":"A731","pred":"tao:has_database_id","subj":"731","obj":"MESH:D006525"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"uding ribavirin and interferon [45]. Furthermore, in a patient with chronic hepatitis and rheumatoid arthritis, a low risk for hepatitis virus reactivation was observed after treatme"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T34","span":{"begin":68,"end":85},"obj":"Phenotype"},{"id":"T35","span":{"begin":90,"end":110},"obj":"Phenotype"},{"id":"T36","span":{"begin":127,"end":136},"obj":"Phenotype"}],"attributes":[{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0200123"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"uding ribavirin and interferon [45]. Furthermore, in a patient with chronic hepatitis and rheumatoid arthritis, a low risk for hepatitis virus reactivation was observed after treatme"}